Perrigo (PRGO) Gains from Investment Securities (2012 - 2025)
Perrigo (PRGO) reported Gains from Investment Securities of -$18.8 million for Q4 2025, down 166.9% year-over-year from $28.1 million in Q4 2024, and down 202.17% quarter-over-quarter from $18.4 million in Q3 2025.
Perrigo (PRGO) Gains from Investment Securities (2012 - 2025) Analysis & Trends
Perrigo (PRGO) has 14 years of Gains from Investment Securities data on file, last reported at -$18.8 million in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at -$18.8 million, down 166.9% year-over-year; the trailing twelve-month figure through Mar 2026 was -$400000.0 (down 101.4% YoY), and the FY2024 annual result was $28.1 million, changed N/A from the prior year.
- Gains from Investment Securities declined to -$18.8 million in Q4 2025 per PRGO's latest filing, from $18.4 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $28.1 million in Q4 2024 and troughed at -$18.8 million in Q4 2025.
- A 5-year average of $2.8 million and a median of $100000.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities plunged 175.47% in 2023, then surged 802.5% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at -$1.5 million in 2021, then soared by 453.33% to $5.3 million in 2022, then sank by 175.47% to -$4.0 million in 2023, then surged by 802.5% to $28.1 million in 2024, then slumped by 166.9% to -$18.8 million in 2025.
- Business Quant data shows PRGO's Gains from Investment Securities at -$18.8 million in Q4 2025, $18.4 million in Q3 2025, and $400000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18.80 Mn |
| Dec 31, 2025 | -18.80 Mn |
| Sep 27, 2025 | 18.40 Mn |
| Sep 27, 2025 | 18.40 Mn |
| Mar 29, 2025 | 400,000.00 |
| Mar 29, 2025 | 400,000.00 |
| Dec 31, 2024 | 28.10 Mn |
| Dec 31, 2024 | 28.10 Mn |
| Dec 31, 2023 | -4.00 Mn |
| Dec 31, 2023 | -4.00 Mn |
| Jul 1, 2023 | 100,000.00 |
| Jul 1, 2023 | 100,000.00 |
| Apr 1, 2023 | 3.90 Mn |
| Apr 1, 2023 | 3.90 Mn |
| Dec 31, 2022 | 5.30 Mn |
| Dec 31, 2022 | 5.30 Mn |
| Oct 2, 2021 | -1.50 Mn |
| Oct 2, 2021 | -1.50 Mn |
| Jul 3, 2021 | -1.00 Mn |
| Jul 3, 2021 | -1.00 Mn |